NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-021-2019-0-BE-10 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN BE EP 14750115.9 Pending
NIAID E-021-2019-0-ES-13 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN ES EP 14750115.9 Pending
NIAID E-021-2019-0-FR-14 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN FR EP 14750115.9 Pending
NIAID E-021-2019-0-DE-12 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN DE EP 14750115.9 Pending
NEI E-241-1999-0-US-09 Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices US DIV 15/045,752 Abandoned
NLM E-111-2016-5-US-01 Novel CRISPR Enzymes And Systems US 62/296,522 Abandoned
NIMH E-345-2013-0-US-06 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches US National Stage 14/912,392 1082-08-17 Issued PDF
NIMH E-448-2013-0-US-04 DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS) US CON 15/045,146 9804171 Issued PDF
NIAID E-031-2006-0-US-05 Chlamydia Vaccine US DIV 15/043,975 1042-08-29 Issued PDF
NCI E-136-2018-0-US-01 Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab US 62/295,421 Abandoned
NCI E-081-2016-0-US-01 Interferon Lambda 4 Compositions and Use Thereof in the Prevention and Treatment of Neuroinvasive Disease US 62/294,836 Abandoned
NCI E-078-2016-0-US-01 RNA/DNA Hybrid Nanoparticles Modified with Single Stranded RNA Toeholds and Uses Thereof US 62/294,848 Abandoned
NCI E-267-2016-0-CA-03 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases CA National Stage 3012820 Pending
NCI E-267-2016-0-PCT-02 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases PCT PCT PCT/US16/017714 Expired
NCATS E-040-2015-0-FR-11 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS FR EP 16749864.1 Issued
NCATS E-040-2015-0-DE-10 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS DE EP 16749864.1 Issued
NCATS E-040-2015-0-GB-12 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS GB EP 16749864.1 Issued
NCATS E-040-2015-0-EP-06 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS EP National Stage 16749864.1 Issued
NCATS E-040-2015-0-CA-09 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS CA National Stage 2976449 Issued
NCATS E-040-2015-0-CN-04 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS CN National Stage 201680020467.X Issued
NCATS E-040-2015-0-JP-05 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS JP National Stage 2017-560888 Issued
NCATS E-040-2015-0-AU-08 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS AU National Stage 2016219231 Issued
NCATS E-040-2015-0-PCT-02 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS PCT PCT PCT/US2016/017504 Expired
NCI E-065-2015-0-AU-03 Griffithsin Mutants AU National Stage 2016219434 Issued
NCI E-065-2015-0-LT-13 Griffithsin Mutants LT EP 16710345.6 Issued
NCI E-065-2015-0-IE-12 Griffithsin Mutants IE EP 16710345.6 Issued
NCI E-065-2015-0-FR-10 Griffithsin Mutants FR EP 16710345.6 Issued
NCI E-065-2015-0-DE-08 Griffithsin Mutants DE EP 16710345.6 Issued
NCI E-065-2015-0-EP-05 Griffithsin Mutants EP National Stage 16710345.6 Issued
NCI E-065-2015-0-GB-11 Griffithsin Mutants GB EP 16710345.6 Issued
NCI E-065-2015-0-ES-09 Griffithsin Mutants ES EP 16710345.6 Issued
NCI E-065-2015-0-CA-04 Griffithsin Mutants CA National Stage 2976337 Pending
NCI E-065-2015-0-PCT-02 Griffithsin Mutants PCT PCT PCT/US16/017267 Expired
NCI E-093-2016-0-US-01 Inducible Arginase US 62/293,513 Abandoned
NCI E-051-2016-0-US-01 Method of Sensitizing Cancer Cells To The Cytotoxic Effects of Apoptosis Inducing Ligands in Cancer Treatment US 62/292,974 Abandoned
NIAID E-158-2007-3-US-04 Live Attenuated Virus Vaccines for La Crosse Virus and other BunyAViridae US DIV 15/018,857 9884104 Abandoned PDF
NCI E-101-2016-0-US-01 GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) US 62/292,789 Abandoned
NIAID E-230-2015-0-US-01 Recombinant HIV-1 Envelope Proteins and Their Use US 62/292,750 Abandoned
NINDS E-101-2012-1-UA-19 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS UA National Stage a201600974 Pending
NICHD E-120-2015-0-US-20 Method For On-demand Contraception US CON 15/016,845 10159681 Issued PDF
NCI E-494-2013-0-CN-05 Methods of Preparing Anti-human Papillomavirus Antigen T Cells CN National Stage 201480044285.7 Issued
NCI E-494-2013-0-RU-08 Methods of Preparing Anti-human Papillomavirus Antigen T Cells RU National Stage 2016103614 Issued
NCI E-495-2013-0-CN-05 Anti-Human Papillomavirus 16 E6 T Cell Receptors CN National Stage 201480044286.1 Issued
NCI E-293-2010-0-US-04 Lipopeptide Inhibitors Of RAS Oncoprotein US DIV 15/015,940 Abandoned
NINDS E-101-2012-1-EA-09 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS EA National Stage 201600093 Pending
NCI E-066-2016-0-US-01 Fulvestrant Improves Immune-mediated Cytotoxic Lysis Of Cancer Cells US 62/290,117 Abandoned
NCI E-508-2013-2-BR-03 M971 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE BR National Stage 112016002268-8 Issued
NCI E-508-2013-2-NZ-09 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE NZ National Stage 716568 Issued
NCI E-508-2013-2-JP-08 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE JP National Stage 2016-531936 Issued
NCI E-080-2008-0-US-05 Human Monoclonal Antibodies Specific for CD22 US DIV 15/012,023 9598492 Issued PDF